Giving them additional funding for it would speed things along, but the White House already knows this and Congress is continuing to not provide the funds.
It’s not clear that money is the bottleneck for either Moderna or Pfizer. The bottleneck is likely in bureaucracy and the Biden administration could likely reduce bureaucracy with executive orders without congressional involvement.
It’s not clear that money is the bottleneck for either Moderna or Pfizer. The bottleneck is likely in bureaucracy and the Biden administration could likely reduce bureaucracy with executive orders without congressional involvement.